S&P 500 7543.64 +0.81%
NASDAQ 26206.89 +1.30%
TASI 10808.43 -0.42%
Oil (WTI) 72.30 +0.31%
Oil (Brent) 76.58 +0.37%
VIX 15.82 -0.13%
Gold 4114.50 -0.64%
USD/SAR 3.75 +0.00%

Moderna, Inc.

MRNA · Healthcare · · USD
76.56 USD
+0.00 (3.74%)
● Updated 2026-07-10 15:07 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

89
/ 100
Technical 100
Trend & RS 100
Momentum 100
Fundamental 67
Macro 78
Liquidity 40
ComponentScoreWeight
Technical 100.0 20%
Trend & RS 99.6 30%
Momentum 100.0 15%
Fundamental 66.7 10%
Macro 78.3 20%
Liquidity 40.5 5%

Trade Setup

Entry 76.56
Stop Loss 66.46 (13.2%)
Target 1 (1:1) 86.66 (+13.2%)
Target 2 (2:1) 96.76 (+26.4%)
ATR(14) 5.05 (6.6%)
Risk per Share 10.10
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 62.1 +0.48
Momentum 100.0 +2.00
Quality 18.2 -1.27
Composite 60.1

Quality Scores

Piotroski F-Score 3 /9 — Weak
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 14.96 Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio N/A 22.0 Inline
P/B Ratio 4.1 4.0 Inline

Comparing against Healthcare median multiples.

Position Sizing — Kelly Criterion

4.8%
Recommended Size
56.43%
Full Kelly
28.22%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 89/100. Estimated win rate 67%, avg win 10.4%, avg loss 3.2%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
67.57
RSI(14)
7.1782
MACD

Relative Strength (RS) IMPROVING

98
/ 99
RS Rating
O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+35.5% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (3d since high)
Sector Outperformance +37.5% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 67.57 NEUTRAL
Macd 7.1782 BULLISH
Ma Cross 54.73 / 42.18 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.44x LOW

Key Levels

LevelPrice
52-Week High85.60
Bollinger Upper86.17
SMA(200)42.18
SMA(50)54.73
SMA(20)64.53
Current Price76.56
Bollinger Lower42.89
52-Week Low22.28
ATR(14)5.05

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-07-02 Normal 1.41x Normal bar — no special VSA pattern
2026-07-06 Normal 1.73x Normal bar — no special VSA pattern
2026-07-07 Normal 0.87x Normal bar — no special VSA pattern
2026-07-08 Normal 0.66x Normal bar — no special VSA pattern
2026-07-09 Normal 0.44x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 72.41 Above Kijun
Kijun-sen (26) 64.75 Base line
Senkou A 68.58 Leading span A
Senkou B 64.64 Leading span B
Cloud 64.64 – 68.58 Bullish (Green)
Price vs Cloud 76.56 Above Cloud
Chikou Span 45.64 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH
BB: 42.89 – 86.17  |  KC: 56.42 – 72.64

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bullish RSI 26

Anchored VWAP

VWAP: 46.57 Anchor: 2025-11-21 (52w Low) ABOVE AVWAP +64.4%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/MRNA

Valuation

MetricValue
Market Cap30.38B
P/E (TTM)N/A
Forward P/EN/A
P/B4.10
EPS-8.14

Financial Health

MetricValue
Revenue Growth2.6%
Profit Margin-1.4%
ROE-36.6%
Debt/Equity17.52
Current Ratio2.41
Dividend YieldN/A
Payout RatioN/A
Beta0.94

Trading Data

76.56
Open
76.56
Day High
76.56
Day Low
4.33M
Volume (0.5x avg)

Recent News (8)

Why Moderna (MRNA) Stock Is Trading Up Today
StockStory · 2026-07-09
Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion
Simply Wall St. · 2026-07-09
Moderna secures up to 24 million RSV vaccine dose contract with Europe
Pharmaceutical Technology · 2026-07-09
RBC Capital Raises its Price Target on Moderna (MRNA)
Insider Monkey · 2026-07-09
Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?
Simply Wall St. · 2026-07-09
Update: Dow Logs Worst Day in 4 Weeks Amid Renewed US-Iran Tensions
MT Newswires · 2026-07-08
US Equity Markets Mixed After Trump Warns of Additional Strikes on Iran
MT Newswires · 2026-07-08
Why Moderna Stock Is the S&P 500’s Big Loser Today
Barrons.com · 2026-07-08

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —